Several studies have reported that GvHD is exacerbated in CD1d−/− or Jα18−/− mice and that stimulation of iNKT cells can increase anti-leukemia responses while simultaneously mitigating the severity of GvHD (100). This evidence concerns the gene CD1D and graft versus host disease.